PeproTech Inc.
Originally published online as doi:10.1189/jlb.0905537 on December 19, 2005

Published online before print December 19, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0905537v1
79/3/417    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhat, R.
Right arrow Articles by Watzl, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhat, R.
Right arrow Articles by Watzl, C.
(Journal of Leukocyte Biology. 2006;79:417-424.)
© 2006 by Society for Leukocyte Biology

Fine-tuning of immune responses by SLAM-related receptors

Rauf Bhat, Philipp Eissmann, Johanna Endt, Sabrina Hoffmann and Carsten Watzl1

Institute for Immunology, University Heidelberg, Germany

1 Correspondence: Institute for Immunology, University Heidelberg, INF 305, 69120 Heidelberg, Germany. E-mail: carsten.watzl{at}urz.uni-heidelberg.de

The modulation of antigen receptor signals is important for a productive immune response. The main function of the recently identified members of the signaling lymphocyte activating molecule (SLAM)-related receptors (SRR) is the fine-tuning of immune cell activation. Disruption of SRR function is the cause for severe immune disorders such as X-linked lymphoproliferative syndrome (XLP), where XLP patients carry a mutation in SLAM-associated protein (SAP) (SH2D1A), an important adaptor molecule for the signal transduction of SRR. Recent data also suggest that SRR may play a role in autoimmune diseases and the function of hematopoietic stem and progenitor cells. Here, we review the current understanding of SRR function in different immune cells.

Key Words: T cells • NK cells • activation • costimulation • Th1/2 polarization




This article has been cited by other articles:


Home page
 BloodHome page
N. A. Watkins, A. Gusnanto, B. de Bono, S. De, D. Miranda-Saavedra, D. L. Hardie, W. G. J. Angenent, A. P. Attwood, P. D. Ellis, W. Erber, et al.
A HaemAtlas: characterizing gene expression in differentiated human blood cells
Blood, May 7, 2009; 113(19): e1 - e9.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-T. Tai, E. Soydan, W. Song, M. Fulciniti, K. Kim, F. Hong, X.-F. Li, P. Burger, M. J. Rumizen, S. Nahar, et al.
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells
Blood, April 30, 2009; 113(18): 4309 - 4318.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. D. Hsi, R. Steinle, B. Balasa, S. Szmania, A. Draksharapu, B. P. Shum, M. Huseni, D. Powers, A. Nanisetti, Y. Zhang, et al.
CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
Clin. Cancer Res., May 1, 2008; 14(9): 2775 - 2784.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. C. Hoffmann, C. Schellack, S. Textor, S. Konold, D. Schmitz, A. Cerwenka, S. Pflanz, and C. Watzl
Identification of CLEC12B, an Inhibitory Receptor on Myeloid Cells
J. Biol. Chem., August 3, 2007; 282(31): 22370 - 22375.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Eissmann and C. Watzl
Molecular Analysis of NTB-A Signaling: A Role for EAT-2 in NTB-A-Mediated Activation of Human NK Cells.
J. Immunol., September 1, 2006; 177(5): 3170 - 3177.
[Abstract] [Full Text] [PDF]